{"name":"Infante, Javier Molina, M.D.","slug":"infante-javier-molina-m-d","ticker":"","exchange":"","domain":"","description":"Infante, Javier Molina, M.D. is a specialty pharmaceutical company focused on developing and marketing gastrointestinal treatments. The company has a portfolio of marketed drugs and continues to innovate in the field.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PPI, amoxicillin, metronidazole and clarithromycin","genericName":"PPI, amoxicillin, metronidazole and clarithromycin","slug":"ppi-amoxicillin-metronidazole-and-clarithromycin","indication":"Helicobacter pylori infection eradication in peptic ulcer disease","status":"marketed"}]}],"pipeline":[{"name":"PPI, amoxicillin, metronidazole and clarithromycin","genericName":"PPI, amoxicillin, metronidazole and clarithromycin","slug":"ppi-amoxicillin-metronidazole-and-clarithromycin","phase":"marketed","mechanism":"This is a quadruple therapy regimen that eradicates Helicobacter pylori by combining acid suppression with three antibiotics that target bacterial protein synthesis and DNA.","indications":["Helicobacter pylori infection eradication in peptic ulcer disease","H. pylori-associated gastritis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}